Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial

Published:2018-09-25 Issue:1 Volume:15 Page:
ISSN:1743-7075
Container-title:Nutrition & Metabolism
language:en
Short-container-title:Nutr Metab (Lond)

Author:

Daneshi-Maskooni Milad,Keshavarz Seyed Ali,Qorbani Mostafa,Mansouri Siavash,Alavian Seyed Moayed,Badri-Fariman Mahtab,Jazayeri-Tehrani Seyed Ali,Sotoudeh Gity

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s12986-018-0297-4.pdf

Reference92 articles.

1. Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 11th ed. Oxford: Blackwell Science; 2002. p. 423.

2. Adibi A, Jaberzadeh-Ansari M, Dalili AR, Omidifar N, Sadeghi M. Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD) in Patients with Angina Pectoris. Open J Med Imag. 2013;3:97–101. https://doi.org/10.4236/ojmi.2013.33015 .

3. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.